Raymond James Financial
RJF
$168.36
-0.79%
Raymond James Financial is a diversified financial services firm offering wealth management, investment banking, asset management, and capital markets services to individuals, corporations, and municipalities. It is a leading independent wealth management platform with over 8,900 advisors and $1.7 trillion in client assets, distinguishing itself through a strong focus on the U.S. market and a hybrid model of independent and employee advisors. The current investor narrative centers on the company's ability to sustain revenue growth amid a volatile rate environment, with recent quarterly results showing 12.4% YoY revenue growth and expanding margins, while the stock has rebounded sharply from its 52-week low, driven by optimism around capital markets recovery and resilient fee-based income.…
RJF
Raymond James Financial
$168.36
Related headlines
Investment Opinion: Should I buy RJF Today?
Rating: Buy. Thesis: Raymond James offers a compelling risk/reward with 12.4% revenue growth, expanding margins, and a forward P/E discount to peers, supported by a consensus Buy rating and average target of $182.67 implying 7.3% upside.
Supporting Evidence: The forward P/E of 12.07x is a 25% discount to the industry average of 22.0x, while trailing P/E of 16.39x is near historical highs but justified by 12.4% revenue growth and 14.5% EPS growth. Net margin of 12.8% and ROE of 17.1% demonstrate profitability, and TTM free cash flow of $2.384 billion provides financial flexibility. The analyst consensus is Buy with a mean rating of 2.43, and the average target implies upside. The stock's PEG ratio of 2.76x is elevated, but the forward P/E discount suggests value if earnings grow as expected.
Risks & Conditions: The biggest risks are earnings disappointment (if EPS fails to reach $19.94), multiple compression (if trailing P/E contracts from 16.39x), and macro headwinds (recession or rate cuts). This Buy would upgrade to Strong Buy if the stock pulls back to $160 (analyst low target) or if revenue growth accelerates above 15%. It would downgrade to Hold if revenue growth decelerates below 8% or if net margin falls below 11%. Overall, the stock appears fairly valued relative to its history but undervalued relative to peers on a forward basis.
Sign up to view all
RJF 12-Month Price Forecast
The AI assessment is bullish with medium confidence. Raymond James combines strong revenue growth, healthy margins, and a forward valuation discount to peers, supported by a consensus Buy rating. The key risk is whether earnings growth can meet elevated expectations, but the 12.4% revenue growth and 14.5% EPS growth provide a solid foundation. The stock's recent momentum (+10% in 1 month) and technical breakout near the 52-week high suggest positive sentiment. We would upgrade to high confidence if Q3 FY2026 earnings show accelerating revenue growth above 15% or if the forward P/E remains below 13x. We would downgrade to neutral if revenue growth decelerates below 8% or if the stock fails to hold above $160 support.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Raymond James Financial's 12-month outlook, with a consensus price target around $182.67 and implied upside of +8.5% versus the current price.
Average Target
$182.67
0 analysts
Implied Upside
+8.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$160 - $205
Analyst target range
Raymond James is covered by 12 analysts, with a consensus recommendation of 'Buy' (mean rating 2.43 on a 1-5 scale where 1 is Strong Buy). The average price target is $182.67, implying approximately 7.3% upside from the current price of $170.30. The distribution shows a bullish tilt, with no sell ratings and a mix of Overweight/Equal Weight/Hold. Recent ratings from Morgan Stanley (Equal Weight), Barclays (Overweight), and UBS (Neutral) indicate a balanced but constructive view. The target range spans from $160.00 (low) to $205.00 (high), representing a 28% spread between the most bearish and bullish outlooks. The low target of $160 suggests a potential 6% downside, possibly pricing in margin compression or a slowdown in wealth management growth. The high target of $205 implies a 20% upside, likely assuming accelerating capital markets revenue and continued advisor recruitment. The wide spread indicates moderate uncertainty, but the consensus leans positive. The recent lack of downgrades and steady ratings from major firms like Morgan Stanley and Barclays reinforce the constructive sentiment.
Bulls vs Bears: RJF Investment Factors
Raymond James presents a mixed picture: strong revenue growth, healthy margins, and a forward P/E discount to peers support a bullish case, but the trailing P/E near historical highs, elevated PEG ratio, and recent underperformance versus the S&P 500 temper enthusiasm. The bull case currently has stronger evidence given the 12.4% revenue growth, consensus EPS estimates implying 36% earnings growth, and analyst target upside of 7.3%. However, the single most important tension is whether earnings growth will materialize as expected—if EPS hits $19.94, the forward P/E of 12.07x would be compelling; if growth disappoints, the stock could re-rate lower. The wide analyst target range ($160-$205) underscores this uncertainty.
Bullish
- Strong Revenue Growth Momentum: Revenue grew 12.4% YoY to $4.262 billion in Q2 FY2026, accelerating from prior quarters. This is robust for a financial services firm and driven by wealth management and capital markets recovery.
- Attractive Forward Valuation: Forward P/E of 12.07x is a 25% discount to the industry average of 22.0x, suggesting undervaluation if earnings materialize. Consensus EPS estimates of $19.94 imply significant earnings growth.
- Healthy Profitability and Margins: Operating margin improved to 17.2% in Q2 FY2026, with net income of $544 million and ROE of 17.1%. Gross margin of 90.5% reflects the asset-light wealth management model.
- Strong Free Cash Flow Generation: TTM free cash flow of $2.384 billion provides ample liquidity for dividends, buybacks, and investments. Operating cash flow of $1.099 billion in Q2 easily covers capex and dividends.
Bearish
- Trailing P/E Near Historical Highs: Trailing P/E of 16.39x is near the upper end of its 5-year range of 11x-18x, indicating the market already prices in above-average expectations. Further multiple expansion is limited.
- PEG Ratio Indicates Expensive Growth: PEG ratio of 2.76x suggests the stock is not cheap on a growth-adjusted basis, as earnings growth may not justify the current valuation if it decelerates.
- Low Current Ratio Poses Liquidity Risk: Current ratio of 0.32 is typical for financials but indicates reliance on short-term funding. In a stress scenario, liquidity could become constrained, though operating cash flow is strong.
- Sensitivity to Interest Rate Environment: Net interest income is tied to rate spreads; a declining rate environment could pressure margins. The stock's beta of 0.94 offers limited downside protection in a market downturn.
RJF Technical Analysis
The stock is in a recovery uptrend after a significant correction, with a 1-year price change of +8.98% and the current price of $170.30 trading at 88.5% of its 52-week range ($138.82-$177.66). This positioning near the upper end of the range suggests positive momentum but also potential resistance as it approaches the 52-week high. The stock's beta of 0.94 indicates slightly lower volatility than the S&P 500, providing a defensive tilt within the financial sector. Short-term momentum is strongly bullish, with 1-month and 3-month price changes of +10.08% and +12.89%, respectively, outpacing the S&P 500's gains of 0.6% and 6.29% over the same periods. This acceleration contrasts with the 6-month decline of -0.86%, signaling a sharp reversal from the earlier downtrend and suggesting renewed buying interest. The relative strength indicators (1-month +9.48%, 3-month +6.60%) confirm the stock is outperforming the market in the near term. Key support lies at the 52-week low of $138.82, a level that held during the March 2026 selloff, while resistance is at the 52-week high of $177.66. A breakout above $177.66 would signal a resumption of the longer-term uptrend, while a breakdown below $138.82 could indicate a deeper correction. With a beta of 0.94, the stock is slightly less volatile than the market, which may appeal to risk-averse investors seeking exposure to financials.
Beta
0.94
0.94x market volatility
Max Drawdown
-20.1%
Largest decline past year
52-Week Range
$139-$178
Price range past year
Annual Return
+5.6%
Cumulative gain past year
| Period | RJF Return | S&P 500 |
|---|---|---|
| 1m | +6.0% | +0.3% |
| 3m | +10.9% | +4.7% |
| 6m | -2.0% | +7.5% |
| 1y | +5.6% | +18.4% |
| ytd | +2.9% | +9.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RJF Fundamental Analysis
Revenue growth has been solid, with the most recent quarter (Q2 FY2026, ending March 31, 2026) reporting $4.262 billion, up 12.4% YoY from $3.791 billion in the prior-year quarter. The trailing four-quarter revenue trend shows acceleration: Q3 FY2025 $3.786B, Q4 FY2025 $4.130B, Q1 FY2026 $4.176B, and Q2 FY2026 $4.262B. Growth is driven by the Private Client Group ($2.827B, 66% of total) and RJ Bank ($816M), while Capital Markets ($489M) and Asset Management ($327M) contribute meaningfully. The 12.4% YoY growth rate is robust for a financial services firm, indicating strong client asset accumulation and advisory fee income. Profitability is healthy, with net income of $544 million in Q2 FY2026 and a net margin of 12.8%, up from 13.1% in Q2 FY2025. Gross margin is exceptionally high at 90.5%, typical for asset-light wealth management firms, while operating margin improved to 17.2% from 17.7% a year ago. The company has been consistently profitable, with EPS of $2.76 in Q2 FY2026 versus $2.41 in the prior-year quarter, reflecting a 14.5% increase. The balance sheet is strong, with a debt-to-equity ratio of 0.36 and free cash flow (TTM) of $2.384 billion, providing ample liquidity. Return on equity (ROE) stands at 17.1%, indicating efficient capital utilization. The current ratio of 0.32 is low, but this is typical for financial services firms with short-term liabilities offset by liquid assets. The company generated $1.099 billion in operating cash flow in Q2 FY2026, easily covering capital expenditures of $45 million and dividends of $109 million, with $1.054 billion in free cash flow.
Quarterly Revenue
$4.3B
2026-03
Revenue YoY Growth
+12.4%
YoY Comparison
Gross Margin
90.5%
Latest Quarter
Free Cash Flow
$2.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RJF Overvalued?
Given positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is 16.39x, while the forward P/E is 12.07x, implying the market expects earnings growth of approximately 36% over the next year. This gap suggests optimism about future profitability, supported by consensus EPS estimates of $19.94 for the current fiscal year. Compared to the industry average P/E of 22.0x (estimated), Raymond James trades at a 25% discount, which may reflect its lower growth profile versus tech-driven fintech peers but appears attractive given its stable wealth management franchise. The PEG ratio of 2.76x suggests the stock is not cheap on a growth-adjusted basis, but the forward P/E discount to the sector is notable. Historically, the stock's trailing P/E has ranged from roughly 11x to 18x over the past five years. At 16.39x, it is near the upper end of that range, indicating the market is pricing in above-average expectations. However, the forward P/E of 12.07x is near the lower end, suggesting that if earnings materialize as expected, the stock could be undervalued. The P/B ratio of 2.79x is above the historical average of ~2.3x, reflecting a premium for its strong ROE and asset-light model.
PE
16.4x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 10x~18x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
5.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Raymond James carries a debt-to-equity ratio of 0.36, which is manageable but not negligible. The low current ratio of 0.32 is typical for financial firms but could become a concern if short-term funding markets freeze. Net margin of 12.8% is healthy but sensitive to operating leverage; a slowdown in revenue growth could compress margins. The company's reliance on wealth management fees (66% of revenue) means a market downturn could reduce asset-based fees and advisory income. Free cash flow of $2.384 billion provides a buffer, but any sustained decline in client assets would directly impact earnings.
Market & Competitive Risks: The stock trades at a trailing P/E of 16.39x, near the high end of its 5-year range, leaving limited room for multiple expansion. The forward P/E of 12.07x implies aggressive earnings growth expectations; if the economy slows or capital markets activity disappoints, the stock could de-rate. Competition from larger wealth managers like Morgan Stanley and discount brokerages like Charles Schwab poses a threat to advisor recruitment and fee compression. The beta of 0.94 offers modest market correlation, but the stock underperformed the S&P 500 over the past year, suggesting sector-specific headwinds. Recent news about AI disruption in brokerage and asset management could pressure valuations if technology displaces advisors.
Worst-Case Scenario: A severe recession could reduce client assets, slow capital markets activity, and compress margins. If earnings fall short of consensus, the stock could re-rate to its 52-week low of $138.82, representing a 18.5% decline from the current price of $170.30. In a prolonged downturn, the trailing P/E could contract to 11x (the low end of its 5-year range), implying a price of approximately $110 based on TTM EPS of $10.00, a potential loss of 35% from current levels. The analyst low target of $160 suggests a more moderate 6% downside, but the worst case could be more severe if macro conditions deteriorate sharply.
FAQ
The key risks are: 1) Financial risk: a low current ratio of 0.32 could strain liquidity in a crisis, though operating cash flow of $1.099 billion provides a buffer. 2) Market risk: the stock's trailing P/E of 16.39x leaves limited room for multiple expansion, and a recession could compress it to 11x, implying a 35% downside. 3) Competitive risk: disruption from AI and low-cost brokerages could pressure fees and advisor retention. 4) Macro risk: sensitivity to interest rates and equity markets, with a beta of 0.94 offering limited protection. The most severe risk is a prolonged bear market that reduces client assets and capital markets activity, potentially driving the stock to $138.82 (52-week low) or lower.
The 12-month forecast is based on three scenarios: a bull case (30% probability) with a target of $182-$205, driven by accelerating capital markets revenue and EPS beats; a base case (50% probability) with a target of $170-$183, assuming 10-12% revenue growth and consensus EPS of $19.94; and a bear case (20% probability) with a target of $139-$160, if a recession hits and earnings disappoint. The most likely scenario is the base case, where the stock trades near the analyst average target of $182.67, implying 7.3% upside. Key assumptions include sustained wealth management growth and stable capital markets activity.
RJF's trailing P/E of 16.39x is near the high end of its 5-year range of 11x-18x, suggesting it is fairly valued relative to its own history. However, the forward P/E of 12.07x is a 25% discount to the industry average of 22.0x, implying undervaluation if consensus EPS estimates of $19.94 are achieved. The PEG ratio of 2.76x indicates the stock is not cheap on a growth-adjusted basis, but the strong revenue growth and ROE of 17.1% justify a premium. Overall, the stock appears fairly valued on trailing metrics but undervalued on forward earnings relative to peers, making it a potential value play for growth-oriented investors.
RJF appears to be a good buy for investors with a medium-term horizon, given its 12.4% revenue growth, forward P/E of 12.07x (25% discount to industry average of 22.0x), and analyst consensus Buy rating with 7.3% upside to the average target of $182.67. The biggest downside risk is a recession that could compress earnings and push the stock to the 52-week low of $138.82, an 18.5% decline. For risk-tolerant investors, the risk/reward is favorable if earnings growth continues; for conservative investors, waiting for a pullback to $160 (analyst low target) may offer a better entry. Overall, it is a buy for those who believe in sustained capital markets recovery and wealth management growth.
RJF is best suited for medium- to long-term investment, given its steady wealth management revenue (66% of total) and consistent profitability. The stock's beta of 0.94 indicates slightly lower volatility than the market, making it a defensive growth play. Short-term trading is possible given recent momentum (+10% in 1 month), but the stock's 6-month decline of -0.86% shows it can be choppy. A minimum holding period of 12-18 months is recommended to allow earnings growth to materialize and the forward P/E discount to close. The dividend yield of 1.19% provides a modest income component, but the primary return driver is capital appreciation from earnings growth and multiple expansion.